Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab vs denosumab in elderly women with primary osteoporosis and knee osteoarthritis
jRCT1041190081Completed
- Sponsor
- Nagoya University Hospital
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial in involutional osteoporosis and knee osteoarthritis (OA) comparing Romosozumab arm with Denosumab arm (2 arms). Primary endpoint: Lumbar spine bone mineral density change. Started Jan 2020; status: completed.
02
Drugs
romosozumabdenosumab
03
Conditions
involutional osteoporosisknee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT1041190081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041190081.